Eclore's ¥200M collapse — low-irritation cosmetics killed by competition and founder loss

Eclore Co., Ltd. was a Kobe-based cosmetics and health food company founded in September 2002 with ¥10 million in capital. The company developed and sold low-irritation cosmetics formulated for atopic dermatitis and sensitive skin — shampoo, rinse, body soap, and cleansing products — alongside health foods such as chlorella and cordyceps.

The company reached peak revenue of approximately ¥160 million in the fiscal year ending August 2007. Its low-irritation product line was well received by consumers with sensitive skin conditions. However, as the market for hypoallergenic cosmetics grew, competitors entered the space offering similar products, intensifying price competition. The consumption tax hike and subsequent consumption slump under Abenomics further reduced sales, which fell to approximately ¥20 million by the fiscal year ending August 2022 — an 87.5% decline from peak.

The COVID-19 pandemic delivered another blow to sales. The company cut costs where it could, but the previous representative passed away in April 2024. The new representative attempted to rehabilitate the business but judged the financial situation hopeless. The Kobe District Court ordered bankruptcy commencement on March 14, 2025 with approximately ¥200 million in liabilities against revenue that had fallen to a fraction of its peak.